Tonix Pharmaceuticals Holding Corp
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | -100.0% | – | – | – | – | – | – | – | -100.0% | – | -13.9% | +29.9% | +29.8% | |
| – | +139.1% | – | – | +97.2% | +63.4% | +154.0% | +74.1% | -19.1% | -45.4% | +23.6% | +9.5% | +75.2% | +82.8% | +21.4% | -95.8% | +63.8% | +10.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -23.1% | +95.0% | |
| – | – | – | – | +123.1% | +80.0% | +300.4% | +90.7% | -19.6% | -53.2% | +31.6% | +3.6% | +98.8% | +90.4% | +18.9% | +5.8% | -53.3% | +10.0% | |
| – | -1.1% | -1.0% | +16,078.7% | +83.7% | +53.0% | +44.9% | +40.0% | -17.6% | -23.8% | +10.3% | +21.4% | +35.0% | +63.5% | +28.7% | +15.0% | -90.2% | +2,478.9% | |
| – | -1.1% | +27.8% | +18,961.9% | +97.2% | +63.4% | +154.0% | +74.1% | -19.1% | -45.4% | +23.6% | +9.5% | +75.2% | +82.8% | +21.4% | +8.3% | +14.5% | -6.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +1,661.2% | -99.8% | -100.0% | – | – | – | – | – | – | – | +15,724.0% | – | – | -92.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +46.0% | -42.6% | +18,961.9% | -52.2% | -101.1% | – | – | – | – | – | -201.3% | – | – | – | -100.0% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.